Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer

InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers

(2012) F. Sitas et al.   JNCI-Journal of the National Cancer Institute

Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A Case for Multifactor Disease

(2012) Elaine M. Smith et al.   Journal of Oncology

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer

(2011) K S Anderson et al.   BRITISH JOURNAL OF CANCER

Low human papillomavirus prevalence in head and neck cancer: results from two large case–control studies in high-incidence regions

(2011) Karina Braga Ribeiro et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

(2011) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets

(2010) Angela M. Hong et al.   VACCINE

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

(2009) Elaine M. Smith et al.   INTERNATIONAL JOURNAL OF CANCER

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?

(2009) Anders Näsman et al.   INTERNATIONAL JOURNAL OF CANCER

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY